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論文内容要約 
 
  
First section: Introduction 
Bispecific antibodies are non-natural antibodies reconstructed from two distinct monoclonal antibodies. The two different 
Fvs in a bispecific antibody simultaneously bind to two target antigens, and the formation of linkages between the two target 
antigens on cell surfaces can induce synergistic signals in the cells. For cancer therapy, cross-linking of immune cells with 
cancer cells induces the immune cells to damage the cancer cells. Especially, bispecific antibodies can target highly cytotoxic T 
cells, which are not activated by natural antibodies. Because of their abundance, proliferation capacity, and serial killing action, 
T cells can effectively attack tumors and a bispecific T-cell recruiting antibody can circumvent the mechanisms used by tumors 
to escape from immune effectors. These advantages of  T-cell–recruiting antibodies have driven researchers to generate a 
large number of these antibodies with different cancer targets and bispecific structure formats; the studies have shown that the 
cytotoxic activities of these antibodies depend on the antigen target and the antibody structure format; for instance, changing 
the target can cause a ~103-fold difference in cytotoxicity and the cytotoxicity is strongly dependent on the bispecific structure 
(diabody, single-chain diabody, tandem single-chain Fv, etc) and arrangement of antibody domains. However, the relationships 
between these factors are complicated, and we have no optimized approach for choosing the appropriate Fvs and domain 
arrangements to construct bispecific antibodies with sufficiently high cytotoxicity to be clinically effective. In this thesis, we 
developed a process for screening highly cytotoxic clones by using the T-cell recruiting library, which is comprehensively 
constructed from domain library; so called ‘domain library approach for generating antibody recruiting T-cell (Dolag ArT) 
system’. 
 
 
 
Second section: Construction of a semi high-throughput process for screening highly cytotoxic T-cell recruiting 
bispecific antibodies 
We constructed a variety of bispecific T-cell recruiting antibodies from a series of the Fvs against T-cell receptors (CD3 and 
CD28) and the epidermal growth factor receptor (EGFR) family (EGFR, HER2–4), and critical rules of high cytotoxic 
antibodies are elucidated in the screening process from the clump of bispecific antibodies. We focused on the traditional 
diabody, which has two single-chain Fv (scFv) fragments with swapped heavy-chain variable (VH) and light-chain variable 
(VL) domains dimerized to form bispecific antibodies. For each target epitope, we constructed diabodies with the VH and VL 
domains in different orders, because changing domain arrangement 
in a diabody can cause more than 103-fold cytotoxicity difference. 
We developed a set of rapid operations for constructing the 
expression vectors and for expressing and purifying proteins, to 
make a variety of 100 diabodies with different hetero scFvs and 
domain arrangements. These prepared diabodies were then screened 
for high cytotoxicity in MTS assays to ascertain the critical rules for 
design of antibodies with high cytotoxicity (Fig. 1). The results of 
this screening process demonstrate that cytotoxicity changes 
drastically according to the Fv used and the domain order, and 
provide critical rules for the design of diabodies with high 
cytotoxicity. 
 
 
Third section: Dolag ArT systems for high throughput screening of cytotoxicity and binding affinity without 
purification process 
We improved the high-throughput performance of this screening process by removing protein purification process and 
adding a stage for determining the diabody concentrations in culture supernatant. The diabodies prepared in the second 
section contained tandemly arranged peptide tags at the C-terminus, which allowed the concentration of diabodies in the 
culture supernatant to be detected by using a tag-sandwich enzyme-linked immunosorbent assay. When using a tag-sandwich 
ELISA, careful selection of the capture and detection antibodies was needed. Here, we found that the sensitivity of the assay 
was affected by the Fvs and the structural configuration of the diabodies; however, the diabody concentrations estimated 
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Fig. 1 cytotoxicity screening with IMAC-purified 
LH-type diabodies; step II was applied for the 
clones which showed more than 50% 
cytotoxicity at step I, step III was applied for the 
clones which showed more than 50% 
cytotoxicity at step II, 
from the tag-sandwich ELISA was sufficiently accurate for 
screening the cytotoxicity of unpurified diabodies in our high 
throughput method (Fig. 2).  
Surface plasmon resonance measurement allowed relative 
binding affinity to be determined for unpurified diabodies in culture 
supernatant, and the relative binding affinities of the unpurified 
diabodies were comparable to those of the purified antibodies. Thus, 
in this section, we improved the high-throughput performance of 
cytotoxicity screening and added the analysis process of the binding 
parameters of highly cytotoxic bispecific antibodies in the screening 
method constructed in the second section, which we call Dolag ArT 
(Domain library approach for generating Antibody recruiting 
T-cell). 
 
 
Fourth section: Construction of T-cell reporter assay with the potential of combining in Dolag ArT system 
We constructed a cell reporter assay for measuring T-cell activation induced by diabody format which could be applied in the 
Dolag ArT system. The activation signals in T-cell were only detected by adding diabodies in the coexistence of T-cells and 
cancer cells. When this T-cell reporter assay for 72 diabodies used in the third section was applied, the expressed amount of 42 
diabodies were enough for detecting the T-cell activation signal, implying the potential for incorporating the Dolag ArT system. 
By applying the T-cell reporter assay for 9 diabodies with various properties of binding affinity to EGFR, strong correlation 
between binding affinity to EGFR and T-cell activation ability was observed. On the other hand, there was no correlation 
between binding affinity to CD3 and T-cell activation ability. These results indicate that T-cell activation ability depends on the 
binding affinity of diabody for cancer cell. In addition, we reveled that T-cell activation ability is one of the major factors to 
determine the cytotoxicity against cancer cells. Therefore, the importance of selecting the domain with high binding ability for 
cancer was demonstrated when T-cell recruiting antibodies are designed for cancer therapy. 
 
 
 
Fig. 2 (A) Schematic representation of the 
tag-sandwich enzyme-linked immunosorbent 
assay (ELISA), (B) Detection of diabody HL-31 by 
means of tag-sandwich ELISA. (C) Estimation of 
diabody concentration in culture supernatant 
estimated from 100- and 50-fold-diluted 
supernatants. Undetectable diabodies are 
indicated with asterisks. 
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Fifth section: Combination of Dolag ArT and library approach 
Dolag ArT system has demonstrated the effectiveness for screening promising clones from the library of T-cell recruiting 
antibody. Here, we combined Dolag ArT and library approach: we generated the domain library of cancer-binding domains by 
using phage display method, and the positive library applied for Dolag ArT. Firstly, we tried to get the antibody fragment with 
affinity for cancer target by means of M13 phage display technology. Positive phage clones were amplified via biopanning, and 
the gene fragments of positive antibodies were simultaneously ligated into the gene fragments of bispecific antibodies with 
anti-CD3 antibody fragments to make polyclonal bispecific antibody genes. This process enabled to construct around 300 
positive bispecific antibodies and to isolate bispecific antibodies directly by screening cytotoxicity. Consequently, we got 
several high cytotoxic BiBian clones, and we demonstrated developed process is efficient for screening promising clones. 
 
 
Sixth section: Conclusions 
We constructed ‘Dolag ArT’ system for screening promising T-cell recruiting antibodies focused on cytotoxicity, binding 
affinity and T-cell activation ability. This system enabled us to screen several promising clones for T-cell recruiting antibodies 
with high throughput and probability. In the future, various T-cell recruiting antibodies would be developed by means of Dolag 
ArT system. 
 
